Chief Information Officer | Technology Executive

Date of management change: April 01, 2025 

What Happened?

 

About the Company

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company is developing a broad pipeline of potentially best-in-class oncology candidates, including ZN-c5, an oral selective estrogen receptor degrader (SERD) for ER+/HER2- breast cancer, ZN-c3, a WEE1 inhibitor, ZN-d5, a BCL-2 inhibitor and ZN-e4, an EGFR inhibitor. Zentalis has operations in both New York and San Diego.

 

About the Person

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Di Fabio Andrea, Kuykendall Tod, Jeffrey Lewis Ian, Wackerhagen Jerry, Evangelakos Konstantinos, Lane Glenn, Mherabi Nader, Hoover Alton, DiCesare Michael, Love David, Pascarello Guy

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.